Pricing drugs, selling hype and how we got here in the first place
May 15, 2018 - 15:46
Radio and PodcastLive Radio & Podcasts
Science & Medicine
Doomsdays for Valeant, Biogen and biotech VC
Fierce editors discuss a rough day for Valeant Pharmaceuticals and Biogen, plus the changing in winds in biotech venture capital.
About This Episode
Doomsdays for Valeant, Biogen and biotech VC is an episode from FierceBiotech Radio. Fierce editors discuss a rough day for Valeant Pharmaceuticals and Biogen, plus the changing in winds in biotech venture capital. The episode was published...
Podcast
This episode belongs to FierceBiotech Radio.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Oct 22, 2015, 21:50 long, audio available.
Related Episodes
Continue listening to more episodes from FierceBiotech Radio.
